Article
KRAS and PIK3CA mutation frequencies in patient-derived xenograft models of pancreatic and colorectal cancer are reflective of patient tumors and stable across passages.
The American surgeon - 1 Sept 2014
Tignanelli Christopher J, Herrera Loeza Silvia G, Yeh Jen Jen
Abstract excerpt
One obstacle in the translation of advances in cancer research into the clinic is a deficiency of adequate preclinical models that recapitulate human disease. Patient-derived xenograft (PDX) models are established by engrafting patient tumor tissue into mice and are advantageous because they capture tumor heterogeneity. One concern with these models is that selective pressure could lead to mutational drift and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
